Aleksiev, R., et al., “Influence of Mitomycin C on the Virulence of Escherichia Coli O157:H7 Enterohemorrhagic Strain 933 and Its Rec A Negative Mutant Strain in Peroral Infections of White Mice,” Probl. Infect. Parasit. Dis. 24:32-36 (1997). XP-002105358. |
Armstrong, G.D., et al., “A Phase I Study of Chemically Synthesized Verotoxin (Shiga-Like Toxin) PK-Trisaccharide Receptors Attached to Chromosorb for Preventing Hemolytic-Uremic Syndrome,” Journal of Infectious Diseases 171:1042-1045 (1995). |
Ito, T., et al., “Evaluation of Antibiotics Used for Enterohemorrhagic Escherichia coli O157 Enteritis—Effect of Varius Antibiotics on Extracellular Release of Verotoxin,” Kansenshogaku Zasshi 71: 130-135 (1997). XP-00205350. |
Karch, H., et al., “Growth of Escherichia Coli in the Presence of Trimethoprim—Sulfamethoxazole Facilitates Detection of Shiga-like Toxin Producing Strains by Colony Blot Assay,” Fems Microbiol. Lett. 35: 141-5 (1986). XP-002105355. |
Kobayashi, I. et al., “Therapeutic Effect of Fosfomycin Against Intestinal Infection with Escherichia Coli O157: H7 In a Mouse Model. 2. Therapeutic Effects of Fosfomycin at a Large Oral Dose,” Nippon Kagaku Ryoho Gakkai Zasshi 46: 445-449 (1998). XP-002105353. |
Moriguchi, N., et al., “The Drug Sensitivity of Enterohemorrhagic Escherichia Coli and Antibiotics Treatment for Hemorrhagic Entercolitis—From an Outbreak of Entercolities in Sakai City,” Jpn. J. Antiobiot. 50: 591-6 (1997). XP-002105352. |
Paton, J.C., et al., “Pathogenesis and diagnosis of Shiga Toxin-producing Escherichia Coli Infections,” Clinical Microbiology Reviews 11: 450-479 (1998). XP-002105349. |
Ruggenenti, P., et al., “Treatment of Thrombotic Microangiopahty,” Journal of Nephrology 8: 255-272 (1995). XP-002105348. |
Swerdlow, D.L., et al., “A Waterborne Outbreak in Missouri of Escherichia Coli 0157: H7 Associated With Bloody Diarrhea and Death,” Annals of Internal Medicine 117: 812-819 (1992). XP-002105351. |
Takeda, T., et al., “In Vitro Specific Binding of Shiga Toxin 1 and 2 by TAK-751S (Gb3 analog)” Kansenshogaku Zasshi 72: 924-34 (1998). XP-002105347. |
Ushijima, T., et al., “Environment Factors for Potent Inhibition of Release of Verotoxin of Enterohemorrhagic Escherichia Coli in the Anaerobic Growth Condition,” Igaku to Seibutsugaku 136: 39-44 (1998). XP-002105359. |
Yee, A.J., et al., “Mitomycin C Induction of A Three Thousand-Fold Increase in Synthesis of a Shiga-like Toxin From Enteropathogenic Escherichia-Coli Strain H.1.8,” Abstr. Gen. Meet. Am. Soc. Microbiol. 92: 131, Abstract No. D214 (1992). XP-002105354. |
Yoh, M., et al., “Effect of Antimicrobial Agents, Especially Fosfomycin, on the Production and Release of Vero Toxin by Enterohemorrhagic Escherichia Coli O157: H7,” Fems. Immunol. Med. Microbiol. 19: 57-64 (1997). XP-002105357. |
Yoshino, K., et al., “Use of a Verotoxin-absorbent for Preventing Deuteropathy of Enterohemorrhagic Escherichia Coli Infection,” Chemical Abstracts 127: Abstract No. 103714 (1997). XP-002105360. |
Yoshino, K., et al., “Use of a Verotoxin-absorbent for Preventing Deuteropathy of Enterohemorrhagic Escherichia Coli Infection,” Kagaku Ryoho No Ryoiki 13 1155-1158 (1997). XP-002105346. |
Abbas, S.A., et al., “Tumor-Associated Oligosaccharides I: Synthesis of Sialyl-Lewisa Antigenic Determinant”, Sialic Acids, Proc. Japan-German Symp., Berlin, 22-23 (1988). |
Amvam-Zollo, P., et al., “Streptococcus pneumoniae Type XIV Polysaccharide: Synthesis of a Repeating Branched Tetrasaccharide with Dioxa-Type Spacer-Arms”, Carbohy. Res., 150:199-212 (1986). |
Armstrong, G.D., et al., Infect. Immunol., 55:1294-1299 (1987). |
Armstrong, G.D., et al., J. Infect. Dis., 164:1160-1167 (1991). |
Boyd, et al., Nephron, 51:207-210 (1989). |
Calderwood, et al., Proc. Natl. Acad. Sci. (USA), 84:4364-4368 (1987). |
Chernyak, A.Y., et al., “A New Type of Carbohydrate-Containing Synthetic Antigen: Synthesis of Carbohydrate-Containing Polyacrylamide Copolymers having the Specificity of 0:3 and 0:4 Factors of Salmonella”, Carbohy. Res., 128:269-282 (1984). |
Cimolai, et al., J. Pediatr., 117:676 (1990). |
Cohen, et al., J. Biol. Chem., 262:17088-17091 (1987). |
Cox, D., et al., “A New Synthesis of 4-O-α-D-Galactoopyranosyl-D-Galacto-Pyranose”, Carbohy. Res., 62:245-252 (1978). |
Dahmén, J., et al., “Synthesis of Space Arm, Lipid, and Ethyl Glycosides of the Trisaccharide Portion [α-D-Gal-(1-4)-β-D-Gal(1-4)-β-D-Glc] of the Blood Group pk Antigen: Preparation of Neoglycoproteins”, Carbohy. Res., 127:15-25 (1984). |
Dahmén, J., et al., “2-Bromoethyl Glycosides: Applications in the Synthesis of Spacer-Arm Glycosides”, Carbohy. Res., 118:292-301 (1983). |
DeGrandis, et al., J. Biol. Chem., 264:12520-12525 (1989). |
Ekborg, G., et al., “Synthesis of Three Disaccharides for the Preparation of Immunogens bearing Immunodeterminants Known to Occur on Glycoproteins”, Carbohy. Res., 110:55-67 (1982). |
Fernandez-Santana, V., et al., “Glycosides of Monallyl Diethylene Glycol. A New type of Spacer group for Synthetic Oligosaccharides”, J. Carbohy. Chem., 8(3):531-537 (1989). |
Fügedi, P., et al., “Thioglycosides as Glycosylating Agents in Oligosaccharide Synthesis”, Glycoconjugate J., 4:97-108 (1987). |
Gannon, et al., J. Gen. Microb., 136:1125-1135 (1990). |
Garegg, P.J., et al., “A Synthesis of 8-Methoxycarbonyloct-1-yl O-α-D-Galactopyranosyl-(1-3)-O-β-D-Galactopyranosyl-(1-4)-2-Acetamido-2-Deoxy-β-D-Glucopyranoside”, Carbohy. Res., 136:207-213 (1985). |
Garegg, P.J., et al., “Synthesis of 6- and 6′ -deoxy Derivatives of 4-O-α-D-galactopyranosyl-β-D-galactopyranoside for Studies of Inhibition of Pyelonephritogenic Fimbriated E. coli Adhesion to Urinary Epithelium-Cell Surfaces”, Carbohy. Res., 137:270-275 (1985). |
Head, S., et al., Infect. Immunol., 58:1532-1537 (1990). |
Head, et al., FEMS Microb. Lett., 51:211-216 (1988). |
Ito, et al., Microb. Pathog., 8:47-60 (1990). |
Itoh, T., et al., VTEC Abstracts, p. 19 (1997). |
Jacewicz, et al., J. Exp. Med., 163:1391-1404 (1986). |
Jackson, et al., Microb. Pathog., 2:147-153 (1987). |
Jacquinet, J.C., et al., “Synthesis of Blood-group Substances, Part 11. Synthesis of the Trisaccharide O-α-D-Galactopyranosyl-(1-3)-O-β-D-galactopyranosyl-(1-4)-2-acetamido-2-deoxy-D-glucopyranose”, J.C.S. Perkin, I:326-330 (1981). |
Kameyama, A., et al., “Total Synthesis of Sialyl Lewis X”, Carbohy. Res., 209:c1-c4 (1991). |
Karmali, M.A., et al., J. Clin. Microb., 22:614-619 (1985). |
Koike, K., et al., “Total Synthesis of Globotriaosyl-E and Z-Ceramides and Isoglobotriaosyl-E-Ceramide,” Carbohy. Res., 163:189-208 (1987). |
Lee, R.T., et al., “Synthesis of 3-(2-Aminoethylthio) PropylGlycosides,” Carbohy. Res., 37:193-201 (1974). |
Lemieux, R.U., et al., “The Properties of a ‘Synthetic’ Antigen Related to the Blood-Group Lewis A,” J. Am. Chem. Soc., 97:4076-83 (1975). |
Lindberg, et al., J. Biol. Chem., 262:1779-1785 (1987). |
Lingwood, et al., J. Biol. Chem., 262:8834-8839 (1987). |
Matsuda, E., et al., VTEC Abstracts, p. 108 (1997). |
Okamoto, K., et al., “Glycosidation of Sialic Acid,” Tetrahedron, 47:5835-5857 (1990). |
Oku, et al., Microb. Pathog., 6:113-122 (1989). |
Paulsen, H., “Synthese von oligosaccharid-determinanten mit amid-spacer vom typ des T-antigens,” Carbohy. Res., 104:195-219 (1982). |
Paulsen, “Advances in Selective Chemical Syntheses of Complex Oligosaccharides,” Angew. Chem. Int. Ed. Eng., 21:155-173 (1982). |
Rana, S.S., et al., “Synthesis of Phenyl 2-Acetamido-2-Deoxy-3-O-α-L-Fucopyranosyl-β-D-Glucopyranoside and Related Compounds,” Carbohy. Res., 91:149-157 (1981). |
Robson, et al., J. Pediatr., 117:675-676 (1990). |
Samuel, et al., Infect. Immunol., 58:611-618 (1990). |
Schaubach, R., et al., “Tumor-Associated Antigen Synthesis: Synthesis of the Gal-α-(1-3)-Gal-β-(1-4)-GlcNAc Epitope. A Specific Determinant for Metastatic Progression?”, Liebigs Ann. Chem., 607-614 (1991). |
Schmidt, “New Methods for the Synthesis of Glycosides and Oligosaccharides—Are There Alternatives to the Koenigs-Knorr Method?”, Angew. Chem. Int. Ed. Eng., 25:212-235 (1986). |
Schmitt, et al., Infect. Immun., 59:1065-1073 (1991). |
Scotland, et al., Lancet, ii:885-886 (1991). |
Strockbine, et al., J. Bacteriol., 170:1116-1122 (1988). |
Waddell, et al., Biochem. Biophys. Res. Comm., 152:674-679 (1988). |
Waddell, et al., Proc. Natl. Acad. Sci. (USA), 87:7898-7901 (1990). |
Walterspiel, J.N., et al., Infection, 20:25-29 (1992). |
Weinstein, et al., J. Bacteriol., 170:4223-4230 (1988). |
Yamamoto, T., et al., VTEC Abstracts, p. 115 (1997). |